ITOS - iTeos Therapeutics, Inc.
IEX Last Trade
7.24
-0.160 -2.210%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:34 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$7.40
-0.16
-2.16%
Summary score
12%
Profitability
10%
Dept financing
4%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.94%
Return on assets
0.92%
Return on sales
1.2%
Return on invested capital
20.99%
Total debt ratio
19.88%
Debt ratio change over timeo
-3.24%
Current Ratio
13.4%
Quick Ratio
13.4%
Cash Position Ratio
13.1%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.65%
Return on assets
-5.47%
Return on sales
-197.94%
Return on invested capital
-55.52%
Total debt ratio
11.85%
Debt ratio change over timeo
-1.31%
Current Ratio
19.88%
Quick Ratio
19.88%
Cash Position Ratio
19.33%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
-5.31%
Return on assets
-6.03%
Return on sales
0%
Return on invested capital
-39.72%
Total debt ratio
13.83%
Debt ratio change over time
-1.35%
Current Ratio
13.76%
Quick Ratio
13.76%
Cash Position Ratio
13.29%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-125.09%
Return on assets
-123.81%
Return on sales
-364.13%
Return on invested capital
-75.12%
Total debt ratio
-324.36%
Debt ratio change over time
-3.24%
Current Ratio
-79.35%
Quick Ratio
-79.35%
Cash Position Ratio
-77.84%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ITOS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 2.94% | 10.2% | 35.82% | 7.59% |
| Return on assets | 0.92% | 2.89% | 3.31% | 5.76% |
| Return on sales | 1.2% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | 20.99% | 3.06% | 5.78% | 20.17% |
| Profitability | 32% | 41% | 67% | 79% |
| Total debt ratio | 19.88% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | -3.24% | 295.05% | -10.03% | 1.11% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 19.88% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 19.88% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 19.33% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 4% | 8% | 19% |
| Short-term ratios | ITOS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.65% | 9.95% | 27.09% | 4.01% |
| Return on assets | -5.47% | 2.47% | 2.17% | 3.36% |
| Return on sales | -197.94% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | -55.52% | 1.71% | 5.84% | 9.7% |
| Profitability | 0% | 51% | 79% | 79% |
| Total debt ratio | 11.85% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | -1.31% | 107.3% | -84.55% | 1.71% |
| Dept financing | 3% | 49% | 25% | 6% |
| Current Ratio | 19.88% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 19.88% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 19.33% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 3% | 8% | 17% |